… To our knowledge this is the first such model to be validated in both retrospective HMA-treated
cohorts and in a prospective randomized phase III trial. Risk stratifying patients who were …

… 1000 lower‐risk myelodysplastic syndrome ( MDS ) patients within the European LeukaemiaNet
MDS ( EUMDS ) Registry are described in conjunction with the validation of the revised …

… the IPSS on the basis of retrospective data from over 7000 … score has been developed and
validated that uses a medullary … The MDS Comorbidity Score—a validated score for patients …

… MDS is infrequent but not exceptional. It accounted for 7% of the total MDS in our retrospective
… In the present study, thrombocytosis was not seen exclusively in RARS or 5q- syndrome. …

… validated manner, presence of known recurrent somatic mutations can be helpful and refine
diagnosis and prognosis of patients with MDS… A retrospective study evaluating the impact of …

… We retrospectively collected clinical and hematologic data of … to be included in the prognostic
model, and a validation cohort, in whom we evaluated whether the prognostic value of the …

… and tailoring treatment in myelodysplastic syndromes (MDS). Despite … We validated this new
risk model in a large external single … retrospectively from Moffitt Cancer Center (MCC) MDS …

… Given the validation of WPSS criteria as a prognostic indicator for the course of … disease,
31 cases of which involved MDS. These cases were investigated retrospectively in this study. …

… (out-of-sample) validation, we used different clinically defined patient groups as training and
validation sets. First, we developed a comprehensive risk model using all MDS patients and …

… We conducted a retrospective review of the SEER-Medicare database for 2000-2008. The
… Our findings validate and support the use of the 2 + BCBM claims algorithm in identifying …